FDA Inspection 912381 — Merz North America, Inc.

Merz North America, Inc. — FEI 1012187

The FDA completed an inspection of Merz North America, Inc. on January 26, 2015 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 26, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Raleigh, NC (United States)